Government invests $1.9 million in COVID-19 immunity study of high-risk populations

The federal government is investing $1.9 million for a national study of COVID-19 antibodies that is targeted specifically at some of the more high-risk populations in the country. The investment, announced Wednesday, is being made through Canada's COVID-19 Immunity Task Force (CITF) to the Canadian Partnership for Tomorrow's Health (CanPath), so it can conduct a serological study of 20,000 Canadians in long-term care homes and people living in under-served areas of the country with high numbers